Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond

By /

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

Scroll to Top